Express Pharma
Home  »  Latest Updates  »  IIL to expand its protozoan Vaccine portfolio

IIL to expand its protozoan Vaccine portfolio

11

It aims to control haemoprotozoan diseases to prevent loss of productivity in cattle.

Indian Immunologicals Limited (IIL) has signed MoU with Instituto Nacional de Tecnologia Agropecuaria (INTA) and Littoral Biologics, Argentina for transfer of technology for Bovine Parasitic vaccines in India. Introduction of vaccines against haemoprotozoan infections transmitted by ticks such as Babesiosis and Anaplasmosis will prevent loss in productivity in cattle an immensely benefit dairy farmers.

Dr Manual G Garcia, Director General of Littoral, Dr Nicora Amadeo, President INTA, Dr Cerioni Adolfo Luis, National Coordinator, INTA, Argentina signed the agreement with Indian Immunologicals to transfer technology to produce vaccine against Babesiosis and Anaplasmosis. IIL’s Rakshavac-T (Vaccine against Theileria annulata) is the only vaccine against haemoprotozoan infections in India.

Dr K Anand Kumar, MD, IIL said, “IIL is only vaccine manufacturer in India which is capable of producing effective parasitic vaccines for animals with vast experience in producing vaccine against haemoprotozoan Theileria annulata, since three decades. IIL recently introduced vaccine against Porcine Cysticercosis, a parasitic vaccine for Pigs. This agreement with the Argentinean collaborators will go a long way in uplifting productivity among dairy farmers in India”.

Comments are closed.